IRCT20200623047902N41招募中Unknown
Bioequivalence study of Sacubitril/valsartan 200mg tablet (Bitval) manufactured by Actover Co. versus originator brand in healthy volunteers in fasting condition
Actover company0 个研究点目标入组 37 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Sacubitril/valsartan
研究者
相似试验
招募中
Unknown
Bioequivalence study of ?valsartan/sacobitril 200mg tabletIRCT20200105046010N86Tabriz University of Medical Sciences24
招募中
2 期
Investigating the effect of valsartan sacubitril on left ventricular functioIRCT20240117060713N1Ahvaz University of Medical Sciences92
尚未招募
1 期
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting ConditionsHealthy VolunteersNCT06193187Dr. Reddy's Laboratories (Thailand) Limited48
尚未招募
Unknown
Comparative in vivo evaluation of 2 Sacubitril 97 mg+ Valsartan 103 mg F.C. Tablet and Entresto® 97+103 mg F.C. Tablet formulations.IRCT20180620040164N68Zist Arvand Pharme Ltd.24
招募中
不适用
Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patientsEnd-stage renal failureJPRN-UMIN000048227International University of Health and Welfare45